Arrow ETF Trust (NLTA)

It is 4 AM, and we are flying

Price is .026, up 34%, and volume is 76M.

SilviaJ $NLST Trend Force expects the memory market's revenue to reach $889.3 billion in 2026, while the 2027 forecast stands at a whopping $1.28 trillion.

Counterpoint Research: The DRAM market's revenue is anticipated to increase by 4x in 2026 to $618.7 billion, followed by a 46%

Don't go away mad. Either respond to the charges, or block them so you don't have to see them. Fleeing from the board completely only makes it seem that the charges are true. Are they?

We need those reports on your first-person visits to the Bishop plant, they've been very inform

UNITED STATES PATENT AND TRADEMARK OFFICE https://www.uspto.gov/sites/default/files/documents/ipr2025-01072-dr-paper_30.pdf

and to think i could of dumped those roof shares at better than 350!!! free roof, profit, and principal back with taxs paid, but noooooo..........i want more!!!!!!!

S&P 500 vs. S&P 493: Where smart money is buying in silence right now
Read the Full article here https://www.linkedin.com/pulse/sp-500-illusion-you-reading-headlines-did-actually-do-mirjana-garison-6cz0e/

Charts: SPY Support--- 23% Retrace Fib at 730.31 !

Charts: Falling Channels Confirmed-----ES Lower Trendline 7395----SPY Lower T/L 733.45 !

Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2

LiveRamp Partners with Adobe to Bring Commerce Purchase Data into GenStudio for Commerce Media NetworksJune 23, 2026 3:00 AM
Business WireAdobe GenStudio for Commerce Media Networks addresses key creative, data, and activation needsLiveRamp (NYSE: RAMP),

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i

Clarivate Releases 2025 Sustainability ReportJune 23, 2026 3:00 AM
PR Newswire (US) New report highlights progress against goals and a decline in total carbon emissions class="legendSpanClass"LONDON, class="legendSpanClass"June 23, 2026

Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2

Seeking Alpha article is INCREDIBLY POSITIVE, just read it!!!
It is written Nearly ALL POSITIVE facts and negative opinion, just a real whimper level of faith, trust and risk tolerance. It is also Just incredible to read the nearly bear case scenario of present value pricing lists a HIGHER pr

Tradeweb Launches Spread Trading for European Credit PortfoliosJune 23, 2026 3:00 AM
Business Wire Enables portfolio-level execution on a spread within a single, integrated workflow Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic tradi

As usual, you're a funny guy.

Like a clown.

https://www.youtube.com/watch?v=Pfcy15ZUE2c

What a monster.....Holding 50k from .,28

So now Jack fruit in July.

Significant Failures to Deliver
Yes

Shorts will be active this weak spreading fear and doubt!

is US stock market going to "crash" tomorrow???????

Gonna be a long wait, imo. Tech has to catch itself. Could be the Winner but other tech could suffice or be realized in the next couple years. LWLG could score a nice foothold for a space in the industry, to me this has legit promise and already is in the door, so to speak , but the results need